FR2450251A1 - Derives de l'acide guanidinobenzoique, procede pour leur preparation et compositions pharmaceutiques les contenant - Google Patents

Derives de l'acide guanidinobenzoique, procede pour leur preparation et compositions pharmaceutiques les contenant

Info

Publication number
FR2450251A1
FR2450251A1 FR8004573A FR8004573A FR2450251A1 FR 2450251 A1 FR2450251 A1 FR 2450251A1 FR 8004573 A FR8004573 A FR 8004573A FR 8004573 A FR8004573 A FR 8004573A FR 2450251 A1 FR2450251 A1 FR 2450251A1
Authority
FR
France
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
acid derivatives
guanidinobenzoic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8004573A
Other languages
English (en)
Other versions
FR2450251B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2257279A external-priority patent/JPS55115863A/ja
Priority claimed from JP2257179A external-priority patent/JPS55115865A/ja
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Publication of FR2450251A1 publication Critical patent/FR2450251A1/fr
Application granted granted Critical
Publication of FR2450251B1 publication Critical patent/FR2450251B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245Amino benzoic acid types, e.g. procaine, novocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

DERIVES DE L'ACIDE GUANIDINOBENZOIQUE REPONDANT A LA FORMULE GENERALE (I) (CF DESSIN DANS BOPI) DANS LAQUELLE R ET R SONT DES ATOMES D'HYDROGENE OU DES GROUPES ALKYLES INFERIEURS, ET Z REPRESENTE UN GROUPE SO OU UN GROUPE Z-CO OU Z EST UNE SIMPLE LIAISON OU UN GROUPE METHYLENE, ETHYLENE OU VINYLENE. APPLICATION COMME PRODUITS PHARMACEUTIQUES PRESENTANT UNE ACTIVITE ANTI-PLASMINE ET ANTI-TRYPSINE.
FR8004573A 1979-03-01 1980-02-29 Derives de l'acide guanidinobenzoique, procede pour leur preparation et compositions pharmaceutiques les contenant Granted FR2450251A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2257279A JPS55115863A (en) 1979-03-01 1979-03-01 Guanidinobenzoic acid derivative and its preparation
JP2257179A JPS55115865A (en) 1979-03-01 1979-03-01 Guanidinobenzoic acid derivative and its preparation

Publications (2)

Publication Number Publication Date
FR2450251A1 true FR2450251A1 (fr) 1980-09-26
FR2450251B1 FR2450251B1 (fr) 1983-02-18

Family

ID=26359810

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8004573A Granted FR2450251A1 (fr) 1979-03-01 1980-02-29 Derives de l'acide guanidinobenzoique, procede pour leur preparation et compositions pharmaceutiques les contenant

Country Status (4)

Country Link
US (1) US4283418A (fr)
DE (1) DE3005580A1 (fr)
FR (1) FR2450251A1 (fr)
GB (1) GB2044760B (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0222608A2 (fr) * 1985-11-12 1987-05-20 Ono Pharmaceutical Co., Ltd. Dérivés de l'acide p-guanidino-benzoique et compositions pharmaceutiques ayant ces dérivés comme agent actif
US4843094A (en) * 1985-11-12 1989-06-27 Ono Pharmaceutical Co., Ltd. Derivatives of p-guantidinobenzoic acid and pharmaceutical agents containing them as active ingredient
US5376655A (en) * 1985-11-12 1994-12-27 Ono Pharmaceutical Co., Ltd. Derivatives of p-guanidinobenzoic acid and pharmaceutical agents containing them as an active ingredient

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423069A (en) * 1982-01-20 1983-12-27 University Of Illinois Foundation Contraceptive method
DE3429114A1 (de) * 1984-08-03 1986-02-13 Schering AG, 1000 Berlin und 4709 Bergkamen Substituierte guanidinobenzoesaeurephenylester, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4746737A (en) * 1985-07-26 1988-05-24 Kowa Co., Ltd. Phenyl guanidinobenzoate derivatives which have protease inhibitory activity
JPH0676373B2 (ja) * 1985-12-27 1994-09-28 エーザイ株式会社 グアニジノ安息香酸エステル誘導体
WO1997037969A1 (fr) 1996-04-10 1997-10-16 Ono Pharmaceutical Co., Ltd. Inhibiteur de tryptase derives de guanidino
AU3864000A (en) * 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses
US6849605B1 (en) * 1999-03-05 2005-02-01 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of viral infections
US6489308B1 (en) 1999-03-05 2002-12-03 Trustees Of University Of Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of nitric-oxide-induced clinical conditions
US20040220242A1 (en) * 2003-05-02 2004-11-04 Leland Shapiro Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide induced clinical conditions
US7850970B2 (en) 2003-08-26 2010-12-14 The Regents Of The University Of Colorado Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
EP1934168A2 (fr) * 2006-07-26 2008-06-25 Teva Pharmaceutical Industries Ltd Tridesmethylvenlafaxine et procédés pour la préparation de desmethylvenlafaxine
EP2539313A2 (fr) * 2010-03-29 2013-01-02 Pliva Hrvatska D.O.O. Formes cristallines du fumarate de o-desméthylvenlafaxine
WO2012178102A2 (fr) 2011-06-24 2012-12-27 The Regents Of The Unversity Of Colorado, A Body Corporate Compositions, procédés et utilisations de molécules de fusion de l'alpha-1 antitrypsine
EP2757093B1 (fr) * 2011-09-15 2016-12-07 Astellas Pharma Inc. Composé d'acide guanidinobenzoïque
JP2015504675A (ja) 2012-01-10 2015-02-16 ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド,ア ボディー コーポレイトTHE REGENTS OF THE UNIVERSITY OF COLORADO,a body corporate アルファ−1アンチトリプシン融合分子の組成物、方法、及び使用
CN114805141A (zh) * 2021-01-27 2022-07-29 中国科学院上海药物研究所 4-胍基苯甲酸芳基酯类化合物及其在抗SARS-CoV-2病毒中的用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2289181A1 (fr) * 1974-11-01 1976-05-28 Ono Pharmaceutical Co Nouveaux derives d'acide guanidinobenzoique et composes et procedes pour leur preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1905813A1 (de) * 1968-07-04 1970-03-05 Akad Wissenschaften Ddr 3- oder 4-Guanidobenzoesaeurebenzyl- oder -phenylestern und deren Verwendung als Inhibitoren
JPS5470241A (en) 1977-11-09 1979-06-05 Ono Pharmaceut Co Ltd Guanidinobenzoic acid derivative and its preparation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2289181A1 (fr) * 1974-11-01 1976-05-28 Ono Pharmaceutical Co Nouveaux derives d'acide guanidinobenzoique et composes et procedes pour leur preparation

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0222608A2 (fr) * 1985-11-12 1987-05-20 Ono Pharmaceutical Co., Ltd. Dérivés de l'acide p-guanidino-benzoique et compositions pharmaceutiques ayant ces dérivés comme agent actif
EP0222608A3 (en) * 1985-11-12 1988-09-07 Ono Pharmaceutical Co., Ltd. Derivatives of p-guanidinobenzoic acid and pharmaceutical agents containing them as active ingredient
US4843094A (en) * 1985-11-12 1989-06-27 Ono Pharmaceutical Co., Ltd. Derivatives of p-guantidinobenzoic acid and pharmaceutical agents containing them as active ingredient
US5077428A (en) * 1985-11-12 1991-12-31 Ono Pharmaceutical Co., Ltd. Pharmacologically active derivatives of p-guanidinobenzoic acid
US5376655A (en) * 1985-11-12 1994-12-27 Ono Pharmaceutical Co., Ltd. Derivatives of p-guanidinobenzoic acid and pharmaceutical agents containing them as an active ingredient

Also Published As

Publication number Publication date
DE3005580A1 (de) 1980-09-11
GB2044760B (en) 1983-03-23
US4283418A (en) 1981-08-11
GB2044760A (en) 1980-10-22
DE3005580C2 (fr) 1988-12-22
FR2450251B1 (fr) 1983-02-18

Similar Documents

Publication Publication Date Title
FR2450251A1 (fr) Derives de l'acide guanidinobenzoique, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2421889A1 (fr) Nouveaux derives d'acide thiazolidinecarboxylique-4 utiles comme medicaments antihypertenseurs et procedes pour leur preparation
BE900345A (fr) Composition pharmaceutique ophtalmiques a base d'un derive d'acide phenylacetique.
FR2397403A1 (fr) Nouveaux derives de 1-acyl 2-cyano-aziridine, procede pour leur preparation et compositions pharmaceutiques contenant ces composes
FR2433527A1 (fr) Nouveaux derives de type pyrimidinone, procede pour leur preparation et composition pharmaceutique les contenant
FR2376134A1 (fr) Derives de 6-oxo-prostaglandines, leur procede de preparation et medicaments en contenant
FR2450820A1 (fr) Nouveaux derives d'acides 1- (o-mercaptoacyl) -4,5-dihydropyrazole-5-carboxyliques, utiles notamment comme agents hypotenseurs, et leur procede de preparation
FR2381048A1 (fr) Nouveaux derives de 20,21-dinoreburnamenine, un procede pour leur preparation et leur application comme medicaments
ES8701143A1 (es) Un procedimiento para la preparacion de nuevos aminas terciarias.
FR2457867A1 (fr) Nouveaux derives d'hydroxyamino-eburnane : leur procede de preparation, intermediaires utilises et utilisation comme medicament et comme intermediaire
FR2440353A1 (fr) Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament
BE904588A (fr) (-)-1Beta-ETHYL-1ALPHA-HYDROXYMETHYL-1,2,3,4,6,7,12,12beta alpha-OCTAHYDROINDOLO (2,3-a) QUINOLIZINE, PROCEDE POUR LA PREPARER ET COMPOSITIONS PHARMACEUTIQUES CONTENANT CELLE-CI.
FR2455047A1 (fr) Sels de 1-alkyl-9-bromo-hexahydroindoloquinolizinium, leur procede de preparation, et leur utilisation comme medicament et pour la synthese d'un ester d'acide 10-bromo vincaminique
BE905654A (fr) Derives de la armstrong 2-1,2,4-triazoline-5-one, procede pour leur preparation et leurs utilisations.
FR2455596A1 (fr) Nouveaux antibiotiques presentant une activite antibacterienne, leur procede de production, leur souche servant a leur obtention et les compositions pharmaceutiques les contenant
FR2434812A1 (fr) Procede de preparation de derives d'acide 3-cephem-4-carboxylique 3,7-disubstitue, nouveaux produits ainsi obtenus et leur utilisation pour leur activite antibacterienne
FR2411173A1 (fr) Anthranilates de n-hydroxyalkyl-carboxamides et leur application comme reticulants
FR2445832A1 (fr) Oxyamino eburnanes epimeres, procede pour les preparer et leur utilisation dans une composition pharmaceutique et pour la preparation de derives ester de l'acide apovincaminique
FR2355839A1 (fr) Derives optiquement actifs d'acide benzoxazolyl-propionique, procede pour leur preparation et compositions therapeutiques les contenant
FR2456101A1 (fr) Derives dihalogenes geminaux de pyrimidin-4-one condensees, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2416214A1 (fr) Derives d'acide naphtyl-1 acetique, leur procede de preparation et leur application therapeutique
FR2424928A1 (fr) 1,6-dimesyl-3,4-dimethyl-d-mannitol, procede pour sa preparation et medicaments le contenant
FR2412562A1 (fr) Nouveaux derives de 6'-epi-fortimicines a et b utiles notamment comme agents antibacteriens, procede et intermediaires pour leur preparation et composition pharmaceutique les contenant
FR2456744A1 (fr) Derives de la pyrazolo (1,5-c)quinazoline, procede de preparation de ces derives et medicaments contenant ces derniers
FR2446272A1 (fr) Nouveaux derives substitues du penten-2-yle, leur procede de preparation et leur application dans la synthese d'un precurseur de l'acide chrysanthemique

Legal Events

Date Code Title Description
ST Notification of lapse